Filing Flows › CorMedix (CRMD) › Gross margin
CorMedix (CRMD) gross margin by quarter
CorMedix's gross margin was 75.7% in Q2 2026 (second quarter 2026), -6.8 pts from Q1 2026. Over the last 7 quarters it ranged from 75.7% (Q2 2026) to 96.2% (Q4 2024).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 75.7% | -6.8 pts | -19.6 pts |
| Q1 2026 | 82.5% | -0.9 pts | -13.4 pts |
| Q4 2025 | 83.4% | -5.8 pts | -12.8 pts |
| Q3 2025 | 89.3% | -6.0 pts | — |
| Q2 2025 | 95.3% | -0.6 pts | — |
| Q1 2025 | 95.9% | -0.3 pts | — |
| Q4 2024 | 96.2% | — | — |
Q2 2026 at a glance
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is CorMedix's gross margin?
CorMedix's gross margin was 75.7% in Q2 2026 (second quarter 2026), -6.8 pts from Q1 2026.
How has CorMedix's gross margin changed?
Over the last 7 quarters it ranged from 75.7% (Q2 2026) to 96.2% (Q4 2024).